Neuroendocrine tumor

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Neuroendocrine tumor | |
|---|---|
| |
| Synonyms | NET, carcinoid tumor |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Flushing, diarrhea, wheezing, abdominal pain |
| Complications | Carcinoid syndrome, metastasis |
| Onset | Variable |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutations, sporadic |
| Risks | Family history, multiple endocrine neoplasia |
| Diagnosis | Biopsy, imaging studies |
| Differential diagnosis | Adenocarcinoma, gastrointestinal stromal tumor |
| Prevention | None |
| Treatment | Surgery, chemotherapy, radiation therapy, targeted therapy |
| Medication | Somatostatin analogs, everolimus, sunitinib |
| Prognosis | Variable, depends on stage and grade |
| Frequency | Rare |
| Deaths | Varies |
A Neuroendocrine tumor (NET) is a neoplasm arising from the cells of the endocrine and nervous systems. These tumors often produce hormones, and depending on the type of hormone produced, can lead to various syndromes. NETs can be benign or malignant and can occur anywhere in the body, but are commonly found in the pancreas, lungs, and gastrointestinal tract.

Classification[edit]
- NETs can be classified based on their site of origin, histological appearance, or behavior. The World Health Organization (WHO) classifies NETs into:
- Well-differentiated NETs: These are usually low-grade or intermediate-grade tumors that resemble normal cells.
- Poorly-differentiated Neuroendocrine Carcinomas (NECs): These are high-grade malignancies with an aggressive course.
- Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN): These tumors contain both neuroendocrine and non-neuroendocrine components.
Clinical Presentation[edit]
- The symptoms of a neuroendocrine tumor vary based on the location of the tumor and whether it is a functioning tumor (producing hormones) or non-functioning. Common symptoms include:
- Flushing
- Diarrhea
- Wheezing
- Weight loss
- Abdominal pain
- Skin rash
Diagnosis[edit]
- Diagnosis of NETs involves a combination of imaging, laboratory tests, and pathological assessment:
- Blood tests: To assess hormone levels, such as chromogranin A, and to gauge general health.
- Urine tests: To check for elevated hormone metabolites, such as 5-HIAA.
- Imaging studies: Including CT, MRI, and nuclear imaging like Gallium 68 PET scan to localize the tumor.
- Biopsy: A tissue sample is taken and assessed histologically to confirm the diagnosis.
Treatment[edit]
- Treatment of neuroendocrine tumors depends on the type, grade, and location of the tumor, as well as the patient’s health. Options include:
- Surgery: Used to remove the tumor. In some cases, such as early-stage pancreatic NETs, surgery can be curative.
- Chemotherapy and Radiation therapy: Often used for high-grade or metastatic tumors.
- Hormone therapy: Used to block excess hormone production in functioning tumors.
- Targeted therapy: Such as Everolimus or Sunitinib, used to target specific pathways in tumor cells.
- Peptide Receptor Radionuclide Therapy (PRRT): This is a targeted treatment approach that delivers radioactive material directly to the tumor cells.
Prognosis[edit]
The prognosis of NETs is variable and depends on factors such as tumor grade, stage, location, and the patient's general health. Well-differentiated tumors tend to have a better prognosis compared to poorly differentiated neuroendocrine carcinomas.
See Also[edit]
References[edit]
- National Cancer Institute. (2023). Neuroendocrine Tumors. Retrieved from https://www.cancer.gov/types/neuroendocrine
- American Society of Clinical Oncology. (2023). Neuroendocrine Tumor: Types. Retrieved from https://www.cancer.net/cancer-types/neuroendocrine-tumor/types
- Mayo Clinic. (2023). Neuroendocrine tumors - Symptoms and causes. Retrieved from https://www.mayoclinic.org/diseases-conditions/neuroendocrine-tumors/symptoms-causes/syc-20354132
- Neuroendocrine Tumor Research Foundation. (2023). Diagnosing NETs. Retrieved from https://netrf.org/neuroendocrine-tumors/diagnosing-nets/
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian



